General Information
Revision date
2016-02-15
Product name
Sequestering Compound
Product Synonyms
Sodium Hexametaphosphate, sodium salt
CAS No.
68915-31-1
Manufacturer Name
Wego Chemical Group
Emergency telephone
For leak, fire, spill or accident emergencies call Chemtrec 1-800-424- 9300
Icons in SDS
Company Information
company name
Wego Chemical Group
Section 2
SECTION 2: Hazards identification
OSHA 2 Emergency Overview
Principle Routes of Exposure
skin contact and inhalation Target organs NFPA: HMIS:
Classification (GHS-US)
Not classified
2.2 Label elements
GHS-US Labeling No labeling applicable
2.3 Other hazards
None Acute Effects Inhalation: May cause irritation to the respiratory tract. Symptoms may include coughing and shortness of breath. Eye: May cause irritation, redness and pain. Ingestion: Phosphates are slowly and incompletely absorbed when ingested, and seldom result in systemic effects. Such effects, however, have occurred. Symptoms may include vomiting, lethargy, diarrhea, blood chemistry effects, heart disturbances and central nervous system effects. The toxicity of phosphates is because of their ability to sequester calcium. Systemic acidosis may result as this material is believed to hydrolyze into phosphoric acid when ingested. Carcinogenicity: IARC, NTP, and OSHA do not list Sodium Hexametaphosphate as a carcinogen.
Medical Conditions Generally Aggravated by Exposure
Persons with pre-existing skin disorders or eye problems, jaw/tooth abnormalities, or impaired liver, kidney or respiratory function may be more susceptible to the effects of the substance.
Potential chronic health
May sequester calcium and cause calcium phosphate deposits in the kidneys. Chronic ingestion or inhalation may induce systemic phosphorous poisoning. Liver damage, kidney damage, jaw/tooth abnormalities, blood disorders and cardiovascular effects can result.
